SLERe
Systemic Lupus Egyptian Registry
Project Managers
-
Prof. Abdelazim Al Hefny
Ain Shams University
-
Prof. Walaa El Baz
Al Azhar University
-
Prof. Hesham Hamoud
Al Azhar University
-
Prof. Anna Aboraya
Alexandria University
-
Prof. Nadia Kamel
Ain Shams University
Objectives
-
General Objective
-
Specific Objectives
-
Primary objectives
Transversal phase Assessment of the permanent damage and comorbidity rallies of Egyptian patients Perspectival phase Analyzing the impact of clinical and serum manifestations on accumulation of permanent damage complicate comorbidities, quality of life survival of the patient
-
Secondary objectives
Transversal phase to require synthesis tests currently available to us, evaluating their possible differences in relation to clinical serological subsets, morbidity and center of origin of the patient Perspectival phase, the therapeutic strategies employed in patients with SLE in daily cynical practice, and the reasons for the introduction & the duration of treatment.
-
Inclusion criteria
for the inclusion of clinician and clinical patients and Diagnosis of SLE formulated on the basis of the clinical judgment of a serological documented Duration of disease less than 10 years.
-
Factors of interest (exposure variables)
-
• Demographic variable
-
• Serological subset
-
• Clinical settings (outpatient / hospital / center analysis)
-
Analysis plan